The drug, sarilumab, sold as Kevzara, didn’t show benefits to patients who were hospitalized but not on ventilators. The study will continue with critically ill patients.
Published: April 27, 2020 at 07:55PM
from NYT Health https://ift.tt/2W8RAts
The drug, sarilumab, sold as Kevzara, didn’t show benefits to patients who were hospitalized but not on ventilators. The study will continue with critically ill patients.
Published: April 27, 2020 at 07:55PM
from NYT Health https://ift.tt/2W8RAts